26 January 2021 : Clinical Research
Predictive Value of a Thyroid-Absorbed Dose with a Shorter Effective Half-Life on Efficacy in Graves Disease Patients Receiving Iodine-131 Therapy
Feng Yu1BCEF, Ruiguo Zhang1CDF, Guizhi Zhang1B, Zhaowei Meng1B, Xiaohua Liu1B, Yajing He1B, Jian Tan1D, Renfei Wang1ADG*DOI: 10.12659/MSM.928796
Med Sci Monit 2021; 27:e928796
Table 1 The efficacy after a single RIT for GD patients with shorter Teff.
| Teff | Efficacy: n (%) | Total effectiveness | |||
|---|---|---|---|---|---|
| Euthyroidism | Hypothyroidism | PR | NR or recurrence | ||
| ≤3d | 5 (16.1) | 0 (0.0) | 12 (38.7) | 14 (45.2) | 17 (54.8) |
| 3–5d | 68 (38.4) | 69 (39.0) | 38 (21.5) | 2 (1.1) | 175 (98.9) |
| Total | 73 (35.1) | 69 (33.2) | 50 (24.0) | 16 (7.7) | 192 (92.3) |